African swine fever vaccines
Description
Review of African swine fever virus vaccines as of 2021
African swine fever virus causes an acute haemorrhagic fever in domestic pigs and wild boar
which is invariably fatal. Introduction of the disease into Georgia in 2007 has led to the deaths
of tens of millions of animals across Eastern Europe, Asia and Oceania with serious effects on
animal welfare and global food security. Control of the disease is impaired by the lack of an
effective vaccine and is dependent on strict biosecurity at the farm gate, and rapid diagnosis,
quarantine and slaughter of infected herds. The few pigs that do recover from disease are robustly
protected from a subsequent encounter with the same virus isolate, showing that immunity is
achievable. This review provides a historical perspective on the approaches that researchers have
taken to develop African swine fever vaccines, as well as discussing promising modern techniques
such as targeted gene deleted viruses and viral vectored vaccines.
Files
978-90-8686-910-7_6.pdf
Files
(413.3 kB)
Name | Size | Download all |
---|---|---|
md5:d31f1b13d3853e8683cd2e113e09ff25
|
413.3 kB | Preview Download |
Additional details
Funding
- High Containment BBS/E/I/00007037
- UK Research and Innovation
- Disease Pathogenesis BBS/E/I/00007030
- UK Research and Innovation
- Recognition and control of virus infections BBS/E/I/00007031
- UK Research and Innovation
- Science Services BBS/E/I/00007039
- UK Research and Innovation
- DEFEND – Addressing the dual emerging threats of African Swine Fever and Lumpy Skin Disease in Europe (DEFEND) 773701
- European Commission
- Studentship: Autophagy and African swine fever virus BBS/E/I/00002120
- UK Research and Innovation